Metformine Pharmconsul (Metformin Hydrochloride)

Metformin acts by activating AMP‑activated protein kinase (AMPK), which suppresses hepatic glucose production, reduces intestinal glucose absorption, and enhances peripheral insulin sensitivity. These combined actions lower fasting and post‑prandial blood glucose without stimulating insulin secretion.

The exact dosage of Metformine Pharmconsul is determined by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. Physicians typically start with a low dose and titrate upward as needed.

Safety of metformin during pregnancy or lactation should be evaluated by a healthcare professional. While some guidelines allow limited use in gestational diabetes, the decision depends on risk‑benefit assessment. Breastfeeding mothers should discuss potential exposure with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is the first‑line therapy for type 2 diabetes because of its efficacy, low risk of hypoglycaemia and favourable impact on weight. Compared with sulfonylureas or insulin, it does not cause weight gain and has a well‑established safety profile, though gastrointestinal side effects are more common.

Metformine Pharmconsul should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

The medication is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water. The exact timing and frequency are prescribed by the treating clinician.

The most serious adverse event is lactic acidosis, a rare but life‑threatening condition that can occur in patients with severe renal or hepatic impairment, hypoxia, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain or abdominal discomfort develop.

Metformine Pharmconsul is contraindicated in patients with known hypersensitivity to metformin, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those receiving iodinated contrast agents without appropriate discontinuation.